Table 8.
Cross database recalls for best performing models trained with different frameworks and SVD database.
| Framework | (Feature) task | Hyperfunction | Laryngitis | Leukoplakia | Normal | Reinke’s Edema | Paralysis | Polyp | Average |
|---|---|---|---|---|---|---|---|---|---|
| AVFAD | |||||||||
| CaRLab 2025 | (MFCCDD) /a/ | – | 66 | – | 2 | 52 | 71 | 49 | 48 |
| (MFCCDD) inj. P/N | – | 66 | – | 13 | 39 | 44 | 50 | 42 | |
| USVAC 2025 2 | (Wav2Vec) ensemble | – | 59 | – | 2 | 33 | 32 | 58 | 37 |
| (MFCCDD) inj. P/N | – | 55 | – | 14 | 12 | 48 | 14 | 29 | |
| da Silva Moura 2024 | (UnispeechSAT) phrase | – | 100 | – | 0 | 3 | 99 | 5 | 41 |
| (MFCCDD) inj. P/N | – | 70 | – | 21 | 12 | 73 | 11 | 37 | |
| narrow | (UnispeechSAT) ensemble | – | 86 | – | 0 | 1 | 51 | 0 | 28 |
| (MFCCDD) inj. N | – | 50 | – | 32 | 5 | 48 | 2 | 27 | |
| MEEI | |||||||||
| CaRLab 2025 | (MFCCDD) /a/ | 4 | – | 25 | 49 | 50 | 62 | 86 | 46 |
| (MFCCDD) inj. P/N | 7 | – | 100 | 78 | 0 | 48 | 64 | 50 | |
| USVAC 2025 2 | (MFCCDD) /a/ | 9 | – | 75 | 44 | 50 | 43 | 64 | 48 |
| (Wav2Vec) inj. P/N | 41 | – | 0 | 91 | 50 | 24 | 36 | 40 | |
| da Silva Moura 2024 | (MFCCDD) all | 3 | – | 75 | 84 | 50 | 29 | 86 | 54 |
| (UnispeechSAT) inj. P/N | 16 | – | 100 | 86 | 100 | 0 | 71 | 62 | |
| narrow | (UnispeechSAT) /a/ | 11 | – | 0 | 25 | 50 | 76 | 0 | 27 |
| (UnispeechSAT) inj. P/N | 64 | – | 0 | 73 | 0 | 0 | 36 | 29 | |
| VOICED | |||||||||
| CaRLab 2025 | (MFCCDD) phrase | – | 61 | – | 2 | 67 | 20 | 67 | 43 |
| (Wav2Vec) inj. P/N | – | 47 | – | 56 | 0 | 0 | 33 | 27 | |
| USVAC 2025 2 | (Wav2Vec) /a/phrase | – | 21 | – | 30 | 67 | 20 | 17 | 31 |
| (Wav2Vec) inj. P/N | – | 0 | – | 75 | 0 | 20 | 0 | 19 | |
| da Silva Moura 2024 | (UnispeechSAT) phrase | – | 100 | – | 0 | 0 | 100 | 0 | 40 |
| (Wav2Vec) inj. P/N | – | 0 | – | 79 | 33 | 20 | 33 | 33 | |
| narrow | (MFCCDD) inj. P/N | – | 0 | – | 0 | 0 | 0 | 83 | 17 |
| (UnispeechSAT) /a/ | – | 0 | – | 54 | 33 | 80 | 0 | 33 | |
Bold values mark the best-performing configuration.